Scintillator Materials and PET Imaging for Oncology and Radiation Detection
This community develops materials that convert radiation into visible light for medical imaging and radiation detection, while simultaneously advancing the clinical application of positron emission tomography (PET) for cancer diagnosis and treatment monitoring.
The research is defined by two distinct but interconnected technical streams. The first focuses on the synthesis and characterization of scintillator materials, including organic-inorganic hybrid halides, perovskites, and metal-organic frameworks (MOFs), designed for high-resolution X-ray imaging and neutron detection. The second stream involves the clinical implementation of PET imaging, specifically using 18F-FDG tracers, to evaluate breast cancer, lymphoma, and parathyroid disorders. Recurring methodologies include Monte Carlo simulations for detector design, the development of plastic scintillators, and the optimization of image reconstruction algorithms. The work bridges materials science and clinical nuclear medicine, with a strong emphasis on improving the sensitivity and speed of radiation detectors for both diagnostic and therapeutic contexts.
The community is most prominent in research involving Lutetium, where it accounts for 12.6% of all tracked work, and Technetium, where it represents 8.5% of the total. It also holds a significant share of Thallium research at 3.8%.
The community comprises 33,214 papers, with the highest publication volume in the European Journal of Nuclear Medicine and Molecular Imaging, IEEE Transactions on Nuclear Science, and Nuclear Instruments and Methods in Physics Research Section A.
Recent work is dominated by the development of new scintillator chemistries, including heavy-metal-free quantum dots, thermally responsive copper halides, and ultra-bright lanthanide-based MOFs for real-time 3D X-ray imaging.